FEAS 发表于 2025-3-25 04:25:41
Nicholas D. Hartlep,Daniel P. Scottthe long-term survival of patients with advanced disease remains poor. Different types of classification have been used to stratify patients with GC for shaping the prognosis and treatment planning. Based on new knowledge of molecular pathways associated with different aspects of GC, new pathogeneti陪审团 发表于 2025-3-25 08:23:06
Buffalo Meat Quality and Structure,ment, proliferation, differentiation, and apoptosis. The dysregulation of ncRNAs has been reported in tumor initiation, progression, invasion, and metastasis in various cancers, including gastric cancer (GC). In the past few years, several studies have focused their attention on the understanding ofHay-Fever 发表于 2025-3-25 13:42:35
http://reply.papertrans.cn/39/3809/380822/380822_23.pngsubacute 发表于 2025-3-25 18:10:05
http://reply.papertrans.cn/39/3809/380822/380822_24.pngdefray 发表于 2025-3-25 23:00:48
http://reply.papertrans.cn/39/3809/380822/380822_25.pngSynchronism 发表于 2025-3-26 03:48:53
Diagnosis and Surveillance: Endoscopic Hallmarksitive and specific diagnostic test, especially if combined with endoscopic macrobiopsies and histological examination of the tissue. Today technological advances permit a better diagnosis of tumors, thanks to the use of different technologies in combination with endoscopy. Some examples of new techn黄瓜 发表于 2025-3-26 04:30:09
Pathological Diagnosis and Classification of Gastric Epithelial Tumoursl risk of progression of these lesions to gastric cancer. In this regard, almost all gastric carcinomas (95%) originate from glandular epithelium and are classified as adenocarcinomas. A multiplicity of environmental and genetic factors influences the aetiologies of this heterogeneous group of tumouvitreous-humor 发表于 2025-3-26 08:33:41
http://reply.papertrans.cn/39/3809/380822/380822_28.png冒烟 发表于 2025-3-26 14:46:25
http://reply.papertrans.cn/39/3809/380822/380822_29.png造反,叛乱 发表于 2025-3-26 19:20:23
New Agents in the Treatment of Advanced Gastric Cancer: Targeted Therapy and Immunotherapyave been focused on GC treatment, the introduction of trastuzumab marked the beginning of a new era of target-specific treatments. Considering the diversity of mutations in GC, satisfactory results obtained from various target-specific therapies were expected, yet most of them were unsuccessful in c